Home › Sinus Histiocytosis › New York
Sinus Histiocytosis clinical trials in New York
4 studies for Sinus Histiocytosis are looking for participants at sites in New York.
Cities in New York
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
- Memorial Sloan Kettering Cancer Center, New York
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT05093335Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 8, 2026 · NCT03329274Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
All ages · All sexes · Updated Sep 18, 2025 · NCT04079179International Rare Histiocytic Disorders Registry (IRHDR)
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
All ages · All sexes · Updated Jun 24, 2025 · NCT02285582From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.